User:Qingyl/Hyperprolactinaemia/Bibliography

You will be compiling your bibliography and creating an outline of the changes you will make in this sandbox.

Bibliography

edit

Edit this section to compile the bibliography for your Wikipedia assignment. Add the name and/or notes about what each source covers, then use the "Cite" button to generate the citation for that source.

  • Krøigaard, Sabrina Meyer; Clemmensen, Lars; Tarp, Simon; Pagsberg, Anne Katrine (2022-09-01). "A Meta-Analysis of Antipsychotic-Induced Hypo- and Hyperprolactinemia in Children and Adolescents". Journal of Child and Adolescent Psychopharmacology. 32 (7): 374–389. doi:10.1089/cap.2021.0140. ISSN 1044-5463 [1]
    • This is a meta-analysis from the Journal of Child and Adolescent Psychopharmacology, so it should be a reliable source. It covers the medications that can cause hyperprolactinemia.
  • Capozzi, Anna et al. “Hyperprolactinemia: Pathophysiology and Therapeutic.” Gynecological endocrinology 31.7 (2015): 506–510. Web. [2]
  • Pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia: A systematic review and meta-analysis[3]
  • Thapa S, Bhusal K. Hyperprolactinemia. [Updated 2023 Jul 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.[4]
  • Majumdar A, Mangal NS. Hyperprolactinemia. J Hum Reprod Sci. 2013 Jul;6(3):168-75. doi: 10.4103/0974-1208.121400. PMID: 24347930; PMCID: PMC3853872.[5]
  • Majumdar, Abha, and Nisha Sharma Mangal. “Hyperprolactinemia.” Journal of Human Reproductive Sciences, U.S. National Library of Medicine, July 2013, www.ncbi.nlm.nih.gov/pmc/articles/PMC3853872/. [6]
  • Richardson, Gary; Wang‐Weigand, Sherry (2009-03). "Effects of long‐term exposure to ramelteon, a melatonin receptor agonist, on endocrine function in adults with chronic insomnia". Human Psychopharmacology: Clinical and Experimental. 24 (2): 103–111. doi:10.1002/hup.993. ISSN 0885-6222.[7]

References

edit
  1. Krøigaard, Sabrina Meyer; Clemmensen, Lars; Tarp, Simon; Pagsberg, Anne Katrine (2022-09-01). "A Meta-Analysis of Antipsychotic-Induced Hypo- and Hyperprolactinemia in Children and Adolescents". Journal of Child and Adolescent Psychopharmacology. 32 (7): 374–389. doi:10.1089/cap.2021.0140. ISSN 1044-5463.
  2. Capozzi, Anna; Scambia, Giovanni; Pontecorvi, Alfredo; Lello, Stefano (2015-07-03). "Hyperprolactinemia: pathophysiology and therapeutic approach". Gynecological Endocrinology. 31 (7): 506–510. doi:10.3109/09513590.2015.1017810. ISSN 0951-3590.
  3. Labad, Javier; Montalvo, Itziar; González-Rodríguez, Alexandre; García-Rizo, Clemente; Crespo-Facorro, Benedicto; Monreal, José Antonio; Palao, Diego (2020-08). "Pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia: A systematic review and meta-analysis". Schizophrenia Research. 222: 88–96. doi:10.1016/j.schres.2020.04.031. {{cite journal}}: Check date values in: |date= (help)
  4. Thapa, Sudan; Bhusal, Kamal (2024), "Hyperprolactinemia", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 30726016, retrieved 2024-07-23
  5. Majumdar, Abha; Mangal, NishaSharma (2013). "Hyperprolactinemia". Journal of Human Reproductive Sciences. 6 (3): 168. doi:10.4103/0974-1208.121400. ISSN 0974-1208.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  6. Molitch, Mark E. (2005-08). "Medication-Induced Hyperprolactinemia". Mayo Clinic Proceedings. 80 (8): 1050–1057. doi:10.4065/80.8.1050. ISSN 0025-6196. {{cite journal}}: Check date values in: |date= (help)
  7. Richardson, Gary; Wang‐Weigand, Sherry (2009-03). "Effects of long‐term exposure to ramelteon, a melatonin receptor agonist, on endocrine function in adults with chronic insomnia". Human Psychopharmacology: Clinical and Experimental. 24 (2): 103–111. doi:10.1002/hup.993. ISSN 0885-6222. {{cite journal}}: Check date values in: |date= (help)

Outline of proposed changes

edit

Click on the edit button to draft your outline.